From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,208,292 shares, representing 3.11% for $19 million under the buyback announced on March 22, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.53 USD | -2.30% | +0.24% | -1.67% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.67% | 1.95B | |
-2.99% | 89.49B | |
+2.50% | 40.67B | |
-12.01% | 33.15B | |
+62.48% | 26.45B | |
-19.79% | 14.69B | |
-8.58% | 12.89B | |
-12.34% | 11.54B | |
-43.92% | 11.34B | |
+3.90% | 8.84B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Tranche Update on Catalyst Pharmaceuticals, Inc.'s Equity Buyback Plan announced on March 22, 2021.